A. R. Macrae

发表

A. Jaffe, J. Tu, G. Palomaki, 2007, Clinica chimica acta; international journal of clinical chemistry.

Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury.

A. Jaffe, P. Kavsak, M. Yerna, 2009, Clinical chemistry.

Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms?

A. Jaffe, G. Palomaki, P. Kavsak, 2008, Clinical chemistry.

Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure.

A. Jaffe, J. Tu, G. Palomaki, 2007, Clinical biochemistry.

Analytical comparison of three different versions of a high-sensitivity cardiac troponin I assay over 10years.

A. Jaffe, P. Kavsak, A. Worster, 2017, Clinica chimica acta; international journal of clinical chemistry.

Second and first trimester estimation of risk for Down syndrome: implementation and performance in the SAFER study

P. V. Van Caeseele, G. Knight, G. Palomaki, 2010, Prenatal diagnosis.

Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population.

A. Jaffe, P. Kavsak, Xuesong Wang, 2009, Clinical chemistry.

Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin-naïve emergency department patients.

A. Jaffe, J. Tu, G. Palomaki, 2006, Clinical chemistry.

Long-term health outcomes associated with detectable troponin I concentrations.

A. Jaffe, J. Tu, G. Palomaki, 2007, Clinical chemistry.

2007 universal myocardial infarction definition change criteria for risk stratification by use of a high-sensitivity cardiac troponin I assay.

A. Jaffe, P. Kavsak, Xuesong Wang, 2010, Clinical chemistry.

"Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes.

A. Jaffe, G. Palomaki, P. Kavsak, 2008, Clinica chimica acta; international journal of clinical chemistry.

Vascular versus myocardial dysfunction in acute coronary syndrome: are the adhesion molecules as powerful as NT-proBNP for long-term risk stratification?

A. Jaffe, G. Palomaki, P. Kavsak, 2008, Clinical biochemistry.

The use of a cytokine panel to define the long-term risk stratification of heart failure/death in patients presenting with chest pain to the emergency department.

A. Jaffe, P. Kavsak, D. Ko, 2010, Clinical biochemistry.

A precise semi-automated uricase method for determining uric acid in serum or urine.

A. R. Macrae, 1977, Clinical biochemistry.

Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies.

A. Jaffe, G. Palomaki, P. Kavsak, 2006, Clinical chemistry.

Maternal Prenatal Screening for Fetal Defects

J. Canick, A. R. Macrae, 2004 .

Outcome validation of the Beckman Coulter access analyzer in a second-trimester Down syndrome serum screening application.

S. Tokmakejian, N. Lepage, A. R. Macrae, 2003, Clinical chemistry.

Second trimester serum markers.

J. Canick, A. R. Macrae, 2005, Seminars in perinatology.

Identification of myocardial injury in the emergency setting.

M. Oremus, A. Jaffe, P. Devereaux, 2010, Clinical Biochemistry.

The Relationship between Characteristics of Home Care Nursing Service Contracts under Managed Competition and Continuity of Care and Client Outcomes: Evidence from Ontario.

P. Coyte, H. Laschinger, G. Darlington, 2007, Healthcare policy = Politiques de sante.

The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction.

Peter A Kavsak, Viliam Lustig, Glenn E Palomaki, 2006, American heart journal.

Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction.

A. Jaffe, J. Tu, G. Palomaki, 2007, Clinica chimica acta; international journal of clinical chemistry.

Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide.

A. Jaffe, G. Palomaki, P. Kavsak, 2007, Clinical chemistry.

Identifying Smith–Lemli–Opitz syndrome in conjunction with prenatal screening for Down syndrome

J. Haddow, G. Palomaki, M. Nowaczyk, 2006, Prenatal diagnosis.

Biparietal diameter and crown‐rump length in fetuses with Down's syndrome: implications for antenatal serum screening for Down's syndrome

R. Salonen, N. Wald, G. Palomaki, 1993, British journal of obstetrics and gynaecology.

PAPP-A as a marker of increased long-term risk in patients with chest pain.

A. Jaffe, P. Kavsak, M. Henderson, 2009, Clinical biochemistry.

Increasing cardiac troponin changes measured by a research high-sensitivity troponin I assay: absolute vs percentage changes and long-term outcomes in a chest pain cohort.

A. Jaffe, P. Kavsak, Xuesong Wang, 2010, Clinical chemistry.

Position paper: screening for high-risk pregnancies with maternal serum alpha-fetoprotein MSAFP

A. R. Macrae, 1990 .

Another potential marker linking gender and cardiac mortality: PAPP-A--a new marker in risk stratification for women presenting with chest pain.

A. Jaffe, P. Kavsak, M. Henderson, 2009, Clinica chimica acta; international journal of clinical chemistry.

Long-term health outcomes associated with detectable troponin I concentrations.

A. Jaffe, J. Tu, G. Palomaki, 2007, Clinical chemistry.